PNU-142721

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NamePNU-142721

Drug Alias NamePNU-142721

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionHuman immunodeficiency virus type 1 reverse transcriptase inhibitors

TargetsHuman immunodeficiency virus type 1 reverse transcriptase

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsHIV Infections

ATC CodeN/A